Atomo Diagnostics Ltd has released a press release.
Appendix 4E & Annual Financial Report
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Atomo Diagnostics
- Quarterly Activity Report - 30 June 2021
- Appendix 4C - 30 June 2021
- Access Bio receives FDA clearance for COVID-19 antibody test
- Update to Atomos US market strategy
- Quarterly Activity Report & Appendix 4C - 31 March 2021
Later from Atomo Diagnostics
- FY21 Results Presentation
- Atomo and Access Bio renegotiate supply agreements
- Appendix 4C - 30 September 2021
- Quarterly Activity Report - 30 September 2021
- HIV Self-Test - improved supply & advertising conditions
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics